Singapore: A report published by the Hay Group, titled 'Building the Capabilities of the Next Generation Workforce', has...
Singapore: Clearbridge VitalSigns, a Singapore-based medical device company, is leveraging its flagship product, CardioL...
Singapore: Singapore medtech startup Healint, that develops mobile apps for chronic diseases, has raised over $1 million...
Singapore: Scientists from Institute of Molecular and Cell Biology (IMCB), a research institute under the Agency for Sci...
Singapore: Health Sciences Authority (HSA), which is the national regulator for health products in Singapore, inaugurate...
Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development serv...
Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will gr...
Singapore: US based contract research firm, AMRI, with operations in Asia, has acquired Oso Biopharmaceuticals Manufactu...
Singapore: The Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR), and Flui...
Singapore: A*Star's Institute of Bioengineering and Nanotechnology (IBN), won the Singapore HEALTH (Helping Employees A...
Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the mi...
Singapore: Japan-based drug giant, Chugai pharmaceuticals recently announced that the company planned to invest nearly S...
TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovativ...
Singapore: A team of scientists led by Associate Professor Zeng Qi from A*Star's Institute of Molecular and Cell Biology...
Singapore: In recent years Bangalore has emerged as one of the region's hottest destinations for budding entrepreneurs w...
Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is em...
Singapore: Singapore's gross expenditure on R&D (GERD) recorded a new high of $6 billion (S$7.4 billion) in 2011, ac...
Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriSt...
